Literature DB >> 30082171

Apatinib and etoposide: surprising efficacy of an oral combination.

Charlie Gourley1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30082171     DOI： 10.1016/S1470-2045(18)30444-3

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  2 in total

1.  Effectiveness and prognostic factors of apatinib treatment in patients with recurrent or advanced cervical carcinoma: A retrospective study.

Authors:  Hui Yang; Min Chen; Zijie Mei; Conghua Xie; Yunfeng Zhou; Hui Qiu
Journal:  Cancer Med       Date:  2021-05-13       Impact factor: 4.452

2.  A novel long-sustaining system of apatinib for long-term inhibition of the proliferation of hepatocellular carcinoma cells.

Authors:  Yanli Wang; Zigui Tang
Journal:  Onco Targets Ther       Date:  2018-11-29       Impact factor: 4.147
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.